Presentation TCT 2016 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White November 01, 2016
Presentation TCT 2016 When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran November 01, 2016
Presentation TCT 2016 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: David P. Faxon, C. Michael Gibson November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger November 01, 2016
Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr. October 30, 2016
Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy, Steven J. Yakubov October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann October 30, 2016
Presentation TCT 2016 Reversal of Chronic Anticoagulation: When, What, and How Effective? Presenter: Paul A. Gurbel, James A. Reiffel October 30, 2016
Presentation TCT 2016 Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents Presenter: Paul A. Gurbel, Christopher B. Granger October 30, 2016
Presentation TCT 2016 Antiplatelet Agents: Limitations, Use Recommendations, and Investigational Agents Presenter: David J. Moliterno October 30, 2016
Presentation TCT 2016 Procedural Anticoagulants: Limitations, Use Recommendations and, Investigational Agents Presenter: Paul A. Gurbel, Harvey D. White October 30, 2016
Presentation Fellows 2016 How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy Presenter: Roxana Mehran April 15, 2016
Presentation Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT Presenter: Larry R. Jackson December 21, 2015
Presentation Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure Presenter: Vivek Y. Reddy December 13, 2015
Presentation TCT 2015 Is There a Role for Oral Anticoagulants After PCI? Presenter: Eric R. Bates, Neal S. Kleiman, C. Michael Gibson October 15, 2015
Presentation TCT 2015 Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda October 15, 2015
Presentation TCT 2015 Should You Bridge in Stented Patients Needing Surgery? Presenter: Eric R. Bates, Neal S. Kleiman, David F. Kong October 15, 2015